📖

Novel Therapy Index

active

wiki page Created: 2026-04-02T20:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-ideas-novel-therapy-index

Related Entities

ideas-novel-therapy-index

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

📊 Evidence Profile

Evidence Balance

+0%

Certainty

100%

Debates

Incoming

231

Outgoing

289

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Linked Artifacts (353)

mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%

mentions🧪Circadian-Synchronized LRP1 Pathway Activation70%

mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming70%

mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna60%

mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination60%

mentions🧪Senescence-Activated NAD+ Depletion Rescue60%

mentions🧪Circadian-Synchronized Proteostasis Enhancement60%

mentions🧪Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci60%

mentions🧪TREM2-mediated microglial tau clearance enhancement60%

mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri60%

mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation60%

mentions🧪Microbial Inflammasome Priming Prevention60%

mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation60%

mentions🧪Vocal Cord Neuroplasticity Stimulation60%

mentions🧪Vagal Afferent Microbial Signal Modulation60%

mentions🧪Enteric Nervous System Prion-Like Propagation Blockade60%

mentions🧪Smartphone-Detected Motor Variability Correction60%

mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor60%

mentions🧫Trehalose-induced lysosomal membrane permeabilization and TF50%

mentions🧫Nrf2 inhibitor ML385 mechanism validation experiment50%

mentions🧫iPSC-NPC effects on astrocytes in vitro ICH model50%

mentions🧪Ganglioside Rebalancing Therapy50%

mentions🧪Near-infrared light therapy stimulates COX4-dependent mitoch50%

mentions🧪Mitochondrial Transfer Pathway Enhancement50%

mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%

mentions🧪HCN1-Mediated Resonance Frequency Stabilization Therapy50%

mentions🧪Lysosomal Calcium Channel Modulation Therapy50%

mentions🧫Proposed experiment from debate on Synaptic pruning by micro50%

mentions🧫Tau depletion effects on neuronal development in primary cul50%

mentions🧪Glial Glycocalyx Remodeling Therapy50%

mentions🧫Acteoside treatment in LPS-induced SALI mouse model50%

mentions🧫Normal Aging to Alzheimer's Disease Transition Trigger 50%

mentions🧪Complement C1q Mimetic Decoy Therapy50%

mentions🧫Multi-omics analysis of myricanol effects on gene expression50%

mentions🧫Longitudinal TLR2 reporter gene study in α-synuclein mice50%

mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy50%

mentions🧫Leukocyte gene expression analysis in COVID-19 patients50%

mentions🧫Acteoside effects on RAW264.7 macrophage cells50%

mentions🧪CYP46A1 Overexpression Gene Therapy50%

mentions🧪PARP1 Inhibition Therapy50%

mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%

mentions🧪Hypocretin-Neurogenesis Coupling Therapy50%

mentions🧪Arginine Methylation Enhancement Therapy50%

mentions🧪SIRT6-NAD+ Axis Enhancement Therapy50%

mentions🧫Microglial TREM2 Agonist In Vivo Efficacy50%

mentions🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim50%

mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers50%

mentions🧫tACS Connectivity Trial in Early Alzheimer's50%

mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%

mentions🧪TREM2-Dependent Microglial Senescence Transition50%

mentions🧫AMPK knockdown validation experiment50%

mentions🧫RBG treatment in ApoE-/- atherosclerosis mouse model50%

mentions🧪The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction50%

mentions🧪Circadian Clock-Autophagy Synchronization50%

mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)50%

mentions🧪Purinergic P2Y12 Inverse Agonist Therapy50%

mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%

mentions🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design50%

mentions🧪APOE Isoform Expression Across Glial Subtypes50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧫iPSC-NPC transplantation in ICH animal model50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

mentions🧫Trehalose-induced lysosomal changes and TFEB activation50%

mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise50%

mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio50%

mentions🧪R-Loop Resolution Enhancement Therapy50%

mentions🧪TFEB-PGC1α Mitochondrial-Lysosomal Decoupling50%

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides50%

mentions🧪Selective Acid Sphingomyelinase Modulation Therapy50%

mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue50%

mentions🧫Dexamethasone treatment study in α-synuclein mice50%

mentions🧫Microtubule domain analysis in adult axons50%

mentions🧫Functional validation of trehalose effects on misfolded prot50%

mentions🧫Gandouling protection against brain injury in Wilson's 50%

mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise50%

mentions🧫TREM2 Function in Alzheimer's Disease — From Risk Varia50%

mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%

mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring50%

mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

mentions🧪Orexin-Microglia Modulation Therapy50%

mentions🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P50%

related🧪APOE Isoform Conversion Therapy50%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

mentions🧫s:** - Biochemical binding assays measuring PROTAC selectivi50%

mentions🧫TLR expression in α-synuclein overexpressing mice50%

mentions🧪LRP1-Dependent Tau Uptake Disruption50%

see_also📖Paraptosis in Neurodegeneration45%

see_also📖Lipid Metabolism Dysregulation in Neurodegeneration45%

see_also📖Autosis Pathway in Neurodegeneration45%

see_also📖R-Loop Stress in Neurodegeneration45%

see_also📖Glycosylation in Neurodegeneration45%

see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 45%

see_also📖RNA-Targeted Therapies in Neurodegeneration45%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)45%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration45%

see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration45%

see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration45%

see_also📖Down Syndrome Neurodegeneration Pathway45%

see_also📖FA2H-Associated Neurodegeneration Pathway45%

see_also📖Tertiary Lymphoid Organs in Neurodegeneration45%

see_also📖Japan Neurodegeneration Epidemiology45%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration45%

see_also📖Histone Modification Pathways in Neurodegeneration45%

see_also📖MicroRNA Dysfunction in Neurodegeneration45%

see_also📖Liquid Biopsy in Neurodegeneration45%

see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener45%

see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration45%

see_also📖Amylin Signaling in Neurodegeneration45%

see_also📖Global Neurodegeneration Epidemiology45%

see_also📖Endosomal Sorting Defects in Neurodegeneration45%

see_also📖COVID-19 Neurodegeneration Mechanism45%

see_also📖Serotonergic Dysfunction in Neurodegeneration45%

see_also📖Protein Aggregation Seeds in Neurodegeneration45%

see_also📖Microglial Priming Pathway in Neurodegeneration45%

see_also📖T-Cell Dysfunction in Neurodegeneration45%

see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration45%

see_also📖Familial vs Sporadic Neurodegeneration Comparison45%

see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration45%

see_also📖Sigma-1 Receptor Signaling in Neurodegeneration45%

see_also📖Neural Circuits in Neurodegeneration45%

see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain45%

see_also📖Sex Differences in Neurodegeneration45%

see_also📖Prion Diseases in Neurodegeneration45%

see_also📖Computational Disease Models for Neurodegeneration45%

see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat45%

see_also📖SUMOylation in Neurodegeneration45%

see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration45%

see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio45%

see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration45%

see_also📖Mitochondrial Fusion in Neurodegeneration45%

see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St45%

see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread45%

see_also📖Ribosome Dysfunction in Neurodegeneration45%

see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen45%

see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration45%

see_also📖Galectin-3 Mechanism in Neurodegeneration45%

see_also📖Nitric Oxide Signaling in Neurodegeneration45%

see_also📖Neuropil Threads in Neurodegeneration45%

see_also📖Integrated Stress Response in Neurodegeneration45%

see_also📖India Neurodegeneration Epidemiology45%

see_also📖Neurovascular Unit Dysfunction in Neurodegeneration45%

see_also📖Neuroimaging Biomarkers for Neurodegeneration45%

see_also📖PKR Pathway in Neurodegeneration45%

see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration45%

see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)45%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)45%

see_also📖NRF2 Signaling Pathway in Neurodegeneration45%

see_also📖Disease Progression & Staging in Neurodegeneration45%

see_also📖Advanced Glycation End Products in Neurodegeneration45%

see_also📖PPAR Signaling Pathway in Neurodegeneration45%

see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration45%

see_also📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE45%

see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati45%

see_also📖Protein Aggregation Comparison in Neurodegeneration45%

see_also📖Economic Burden — Neurodegeneration45%

see_also📖IGF-1 Signaling Pathway in Neurodegeneration45%

see_also📖Cortical Involvement and Neurodegeneration in Progressive Su45%

see_also📖Prion-Like Spread in Neurodegeneration45%

see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl45%

see_also📖IL-1 Signaling Pathway in Neurodegeneration45%

see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration45%

see_also📖Prion Protein Metabolism in Neurodegeneration45%

see_also📖Kidney-Brain Neurodegeneration Axis45%

see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration45%

see_also📖Copper Homeostasis in Neurodegeneration45%

see_also📖GDF15/GDF11 Signaling in Neurodegeneration45%

see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio45%

see_also📖Exosomal Biomarkers in Neurodegeneration45%

see_also📖Sleep Disorders in Neurodegeneration45%

see_also📖Gangliosides in Neurodegeneration45%

see_also📖Retinal Degeneration Pathway in Neurodegeneration45%

see_also📖Neuronal Hyperexcitability in Neurodegeneration45%

see_also📖Axon Guidance Pathways in Neurodegeneration45%

see_also📖Endothelin Signaling Pathway in Neurodegeneration45%

see_also📖Neuropeptide Y Signaling in Neurodegeneration45%

see_also📖Homocysteine Neurotoxicity and Neurodegeneration45%

see_also📖Purinergic Signaling in Neurodegeneration45%

see_also📖Cognitive Reserve and Resilience in Neurodegeneration45%

see_also📖Ghrelin Signaling Pathway in Neurodegeneration45%

see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime45%

see_also📖Digital Phenotyping in Neurodegeneration45%

see_also📖Antibody Therapy in Neurodegeneration45%

see_also📖epigenetics-neurodegeneration45%

see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a45%

see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr45%

see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration45%

see_also📖Prognostic Biomarkers in Neurodegeneration45%

see_also📖Manganese-Related Neurodegeneration (Manganism)45%

see_also📖Therapeutic Targets in Neurodegeneration45%

see_also📖Cell-Free DNA Biomarkers in Neurodegeneration45%

see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration45%

see_also📖PLA2G6-Associated Neurodegeneration (PLAN)45%

see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N45%

see_also📖Endocannabinoid System in Neurodegeneration45%

see_also📖P-Body (Processing Body) Pathway in Neurodegeneration45%

see_also📖Orexin Signaling in Neurodegeneration45%

see_also📖Neural Circuit Disruption in Neurodegeneration45%

see_also📖HMGB1 Signaling in Neurodegeneration45%

see_also📖Parthanatos in Neurodegeneration45%

see_also📖Senescent Cell Clearance in Neurodegeneration45%

see_also📖US Neurodegeneration Epidemiology45%

see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)45%

see_also📖Diffusion MRI (DTI) in Neurodegeneration45%

see_also📖Metal Homeostasis Dysregulation in Neurodegeneration45%

see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and45%

see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration45%

see_also📖Pericyte Loss in Neurodegeneration45%

see_also📖interleukin-6-signaling-neurodegeneration45%

see_also📖Hippocampal Neurogenesis in Neurodegeneration45%

see_also📖Dystrophic Neurites in Neurodegeneration45%

see_also📖China Neurodegeneration Epidemiology45%

see_also📖Neurotensin Signaling in Neurodegeneration45%

see_also📖Short Chain Fatty Acids in Neurodegeneration45%

see_also📖Synaptic Biomarkers in Neurodegeneration45%

see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration45%

see_also📖GDNF Signaling Pathway in Neurodegeneration45%

see_also📖mTOR Signaling Pathway in Neurodegeneration45%

see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration45%

see_also📖Potential Impact Measures — Neurodegeneration45%

see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration45%

see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 45%

see_also📖Sleep Dysfunction in Neurodegeneration45%

see_also📖Noradrenergic Signaling Pathway in Neurodegeneration45%

see_also📖acetylcholine-signaling-neurodegeneration45%

see_also📖IL-6 (Interleukin-6) in Neurodegeneration45%

see_also📖Metal Homeostasis in Neurodegeneration45%

see_also📖Lipid Dysregulation in Neurodegeneration45%

see_also📖Molecular Chaperones in Neurodegeneration45%

see_also📖Progesterone Signaling Pathway in Neurodegeneration45%

see_also📖synaptic-vesicle-cycling-neurodegeneration45%

see_also📖DALY Methodology — Neurodegeneration45%

see_also📖mTOR Signaling in Neurodegeneration45%

see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 45%

see_also📖RAN Translation in Neurodegeneration45%

see_also📖Vagus Nerve Pathway in Neurodegeneration45%

see_also📖Paranodal Dysfunction in Neurodegeneration45%

see_also📖Metabolomic Biomarkers in Neurodegeneration45%

see_also📖Cholinergic System Dysfunction in Neurodegeneration45%

see_also📖CaMKII Signaling Pathway in Neurodegeneration45%

see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration45%

see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration45%

see_also📖Exosomal miR-155 in Neurodegeneration45%

see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration45%

see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration45%

see_also📖Convergent Pathways in Neurodegeneration45%

see_also📖RNA Splicing in Neurodegeneration45%

see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 45%

see_also📖NF-kB Signaling Pathway in Neurodegeneration45%

see_also📖S100 Protein Signaling Pathway in Neurodegeneration45%

see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration45%

see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration45%

see_also📖mitochondrial-dysfunction-neurodegeneration-comparison45%

see_also📖European Neurodegeneration Epidemiology45%

mentions🧫TBK1-PAK1IP1-PAK1 signaling pathway analysis44%

mentions🧫Endothelium-specific TBK1 knockdown in atherosclerosis model44%

mentions🧫LC-MS/Western blot analysis of TBK1 in atherosclerotic arter44%

mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau44%

mentions🧫CRISPR Gene Correction Approaches for CBS/PSP44%

mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and44%

mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi44%

mentions🔬What are the mechanisms underlying senolytic therapy for age40%

related🧪Ganglioside Rebalancing Therapy40%

mentions🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br40%

related🧪PARP1 Inhibition Therapy40%

mentions🔬Senescent cell clearance as neurodegeneration therapy40%

mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%

Novel Therapy Index

💬 Discussion